Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Revised Outcome Due Type Error In Annexure E
Revised outcome due type error in Annexure E30-05-2024
Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Revised Outcome Due Type Error In Annexure E
Revised outcome due type error in Annexure EEntero Healthcare Solutions Ltd - 544122 - Statement Of Deviation Or Variation In Utilization Of Funds Raised Under Initial Public Offering - Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements Regulations 2015.
Statement of Deviation or Variation in Utilization of funds raised under Initial Public Offering for the quarter ended March 31, 2024.Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Investor Presentation
Submission of Investor presentation on Audited Financial Results for the quarter and year ended March 31, 2024.Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 29, 2024
Outcome of Board Meeting held on May 29, 2024Entero Healthcare Solutions Ltd - 544122 - Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2024
Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2024Entero Healthcare Solutions Ltd - 544122 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended March 31, 2024Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings call on audited financial results for the Quarter and Year ended March 31, 2024.Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31, 2024Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended March 31, 2024Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Acquisition
The Board of Directors of Entero Healthcare Solutions Limited ("Company") has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held on May 06, 2024.